Cardinal Health Inc.’s $1.99 billion purchase of Cordis Corp. from Johnson & Johnson, announced March 2, is the latest move by the company to leverage its extensive supply chain and marketing reach to sell products with a high physician preference but little clinical differentiation.
“We have focused on categories that show high physician preference with limited clinical differentiation, inefficient supply chains, and ones which...